SiS4 App for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new smartphone app designed to help occasional smokers quit. The app, called the SiS4 mHealth App Intervention, uses positive psychology exercises to boost mood and offers tools for quitting. The trial compares this new app with another app intended for daily smokers to determine which is more effective for nondaily smokers. It suits those who smoke less than daily but at least weekly and want to quit. Participants will use the app daily for seven weeks and complete several surveys over the course of a year. As an unphased trial, this study allows participants to contribute to innovative research that could shape future smoking cessation tools.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using a smartphone app to help quit smoking.
What prior data suggests that the SiS4 app is safe for smoking cessation?
Research has shown that the SiS4 app, designed to help occasional smokers quit, has been tested in earlier studies. These studies evaluated user experiences and the app's effectiveness in aiding smoking cessation. So far, users have reported no serious side effects or major issues. Feedback has improved the app's usability and effectiveness.
As a smartphone tool rather than a medication, the SiS4 app does not cause the physical side effects associated with drugs. Instead, it focuses on user management and its impact on changing smoking habits. Overall, this makes it a low-risk option for those seeking to quit smoking.12345Why are researchers excited about this trial?
Researchers are excited about the SiS4 app for smoking cessation because it offers a fresh, digital approach to help nondaily smokers quit. Unlike traditional methods like nicotine replacement therapy or counseling, SiS4 leverages mobile technology to provide support and engagement directly through a smartphone app. This app focuses on positive reinforcement, encouraging users to "smile instead of smoke," which could make the quitting process more engaging and personalized. Additionally, the app's 7-week structured program aims to support users consistently, providing an innovative alternative to existing smoking cessation options.
What evidence suggests that the SiS4 app is effective for smoking cessation?
This trial will compare the effectiveness of two smartphone apps for smoking cessation. Studies have shown that the SiS4 app, one of the apps tested in this trial, may be effective for occasional smokers. Research indicates that the app uses exercises from positive psychology to help users maintain a positive mindset while quitting. Early findings suggest these exercises can boost users' confidence in their ability to quit smoking. Previous research has also shown that people using the SiS4 app are more likely to stop smoking. Although the SiS4 app is still under evaluation in this trial, these early results are promising for those trying to quit smoking.13567
Who Is on the Research Team?
Bettina Hoeppner, Ph.D., M.S.
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for nondaily smokers in the US who want to quit, can read English, have smoked over 100 cigarettes in their lifetime, and own a smartphone. They must be at least 18 years old and able to use online surveys and apps.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the SiS4 app daily for 7 weeks, including 1 week prior to and 6 weeks post-quit date
Follow-up
Participants complete online surveys to monitor smoking status, attitudes, and well-being at multiple intervals post-quit
What Are the Treatments Tested in This Trial?
Interventions
- mHealth App Intervention for Nondaily Smokers 'SiS4'
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator